We also apply these techniques to model systems in order to identify subgroups of patients who are uniquely sensitive or resistant to targeted therapies, such as poly (ADP - ribose) polymerase (PARP) inhibitors or immune checkpoint blockade. (nyulangone.org)
This imaging approach could also, in the future, help better define which patients with autoimmunity will likely progress to diabetes and classify subgroups of patients who might benefit from different therapeutic strategies. (sciencedaily.com)
Further research should be directed toward identifying coping styles of subgroups of patients at risk for poor adaptation and exploring possible protective factors in order to optimize metabolic control and quality of life. (care.diabetesjournals.org)